CAS: 1260982-43-1
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 2-(PYRROLIDIN-1-YL)-5,6,7,8-TETRAHYDROPYRIDO[4,3-D]PYRIMIDINE REF: IN-DA01ATJ7CAS: 1260982-43-1 | 99% | A consultar | Vie 22 Nov 24 |
 | 2-(PYRROLIDIN-1-YL)-5,6,7,8-TETRAHYDROPYRIDO[4,3-D]PYRIMIDINE REF: 10-F386649CAS: 1260982-43-1 | 97.0% | A consultar | Lun 02 Dic 24 |
 | 2-(Pyrrolidin-1-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine REF: 3D-KAC98243CAS: 1260982-43-1 | Min. 95% | - - - | Producto descatalogado |
2-(PYRROLIDIN-1-YL)-5,6,7,8-TETRAHYDROPYRIDO[4,3-D]PYRIMIDINE
CAS:1260982-43-1
Fórmula:
C11H16N4
Pureza:
99%
Peso molecular:
204.2715
Ref: IN-DA01ATJ7
| 1g | A consultar | ||
| 100mg | 468,00 € | ||
| 250mg | 526,00 € | ||
| 500mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 22 de Noviembre de 2024
![2-(PYRROLIDIN-1-YL)-5,6,7,8-TETRAHYDROPYRIDO[4,3-D]PYRIMIDINE](https://static.cymitquimica.com/products/10/thumb/F386649.jpg)
2-(PYRROLIDIN-1-YL)-5,6,7,8-TETRAHYDROPYRIDO[4,3-D]PYRIMIDINE
CAS:1260982-43-1
Pureza:
97.0%
Peso molecular:
204.27699279785156
Ref: 10-F386649
| 1g | A consultar | ||
| 100mg | A consultar | ||
| 250mg | A consultar | ||
| 500mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 2 de Diciembre de 2024
![2-(Pyrrolidin-1-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine](https://static.cymitquimica.com/products/3D/thumb/KAC98243.jpg)
2-(Pyrrolidin-1-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine
CAS:1260982-43-1
Please enquire for more information about 2-(Pyrrolidin-1-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine including the price, delivery time and more detailed …
Fórmula:
C11H16N4
Pureza:
Min. 95%
Peso molecular:
204.27 g/mol
Ref: 3D-KAC98243
| 1g | Descatalogado | Solicitar información | |
| 5g | Descatalogado | Solicitar información | |
| 10mg | Descatalogado | Solicitar información | |
| 100mg | Descatalogado | Solicitar información | |
| 250mg | Descatalogado | Solicitar información | |
| 500mg | Descatalogado | Solicitar información |
